Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic Oral Bicarbonate Feasibility Study
NCT02531919Phase 1Completed
- Sponsor
- University of Arizona
- Start
- Aug 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sodium bicarbonate in cancer, sponsored by University of Arizona. Primary endpoint: Time to evidence of adherence failure at 120 days. Started Aug 2013; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02531919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531919.